Showing results (281-290 of 478) with videos related to

Sort By:
Pageof 48
Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.
BMC Genetics|February 21, 2004
Multivariate sib-pair linkage analysis of longitudinal phenotypes by three step-wise analysis approachesZheng Guo, Xia Li, Shaoqi Rao, et al.
Mededportal : the Journal of Teaching and Learning Resources|July 22, 2026
Artificial Intelligence and Large Language Models: A Case-Based, Peer-Teaching Workshop for Preclinical Medical StudentsBrendon C Choy, Hariharan Shanmugam, Hyae Won Redden, et al.
BMJ (Clinical Research Ed.)|March 28, 2020
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studiesMyura Nagendran, Yang Chen, Christopher A Lovejoy, et al.
JAMA|April 14, 2005
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trialsGiuseppe De Luca, Harry Suryapranata, Gregg W Stone, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2005
Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury modelKai Wang, Zhongmin Zhou, Ming Zhang, et al.
Circulation|November 4, 2005
Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarctionNikolay Vasilyev, Timothy Williams, Marie-Luise Brennan, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2003
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIbMichael S Lee, Andreas U Wali, Venu Menon, et al.
Cardiology|February 5, 2003
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy)Arno Breeman, Nestor Mercado, Mattie Lenzen, et al.
Circulation|December 11, 2002
Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trialsMarco Roffi, Debabrata Mukherjee, Derek P Chew, et al.
Pageof 48